阅读说明：本技术 一种海泽麦布和HMG-CoA还原酶抑制剂的药物组合物 (Pharmaceutical composition of Haizumab and HMG-CoA reductase inhibitor ) 是由 丁立 代军 冯春荣 代常亮 于 2018-11-23 设计创作，主要内容包括：本发明提供一种药物组合物,其中含有海泽麦布和HMG-CoA还原酶抑制剂,还可以包括碳酸钙、丁羟茴醚、丁羟甲苯、枸橼酸、十二烷基硫酸钠、聚山梨酯、交联羧甲基纤维素钠、交联聚维酮、微晶纤维素、聚维酮、羟丙基纤维素、乳糖、预胶化淀粉、硬脂酸镁和滑石粉中的一种或多种辅料。该组合物可以制成多种剂型,且制剂稳定性好,质量可控。(The invention provides a pharmaceutical composition, which contains Haizumab and an HMG-CoA reductase inhibitor, and also can comprise one or more auxiliary materials of calcium carbonate, butylated hydroxyanisole, butylated hydroxytoluene, citric acid, sodium dodecyl sulfate, polysorbate, croscarmellose sodium, crospovidone, microcrystalline cellulose, povidone, hydroxypropyl cellulose, lactose, pregelatinized starch, magnesium stearate and talcum powder. The composition can be made into various dosage forms, and has good stability and controllable quality.)